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Abstract: 
Chromosome 22q11.2 deletion syndrome (22q11DS) is associated with cognitive deficits and 
morphometric brain abnormalities in childhood and a markedly elevated risk of schizophrenia in 
adolescence/early adulthood. Determining the relationship between neurocognition and 
neuroimaging findings would yield crucial information about childhood neurodevelopment and 
provide a basis for the study of the trajectory that occurs on the pathway to psychosis. We 
compared morphometric brain findings between non-psychotic children with 22q11DS (n = 22) 
and healthy controls (n = 16), and examined the association between neurocognitive functioning 
and morphometric brain findings. Volumetric regional gray matter differences between the 
22q11DS and control subjects were measured, and correlations of the regional gray matter 
volumes and neurocognition were performed. Children with 22q11DS demonstrated reductions 
in gray matter in several brain regions, chiefly the frontal cortices, the cingulate gyrus and the 
cerebellum. The volumetric reductions in these salient areas were associated with poor 
performance in sustained attention, executive function and verbal memory; however, the relation 
of brain volume with cognitive performance did not differ between the patient and control 
groups. Thus, children with 22q11DS demonstrate gray matter reductions in multiple brain 
regions that are thought to be relevant to schizophrenia. The correlation of these volumetric 
reductions with poor neurocognition indicates that these brain regions may mediate higher 
neurocognitive functions implicated in schizophrenia. 
 
Article: 
INTRODUCTION 
Chromosome 22q11.2 deletion syndrome (22q11DS) also known as velocardiofacial or 
DiGeorge syndrome, is the most common chromosomal microdeletion in humans, with an 
incidence of 1 in 2000–4000 live births (Tezenas Du et al., 1996; Shprintzen. 2000). In addition 
to congenital abnormalities and cognitive deficits in childhood (Shprintzen et al., 1981; Golding-
Kushner et al., 1985), a substantial proportion of affected individuals develop major psychiatric 
illnesses in adolescence/early adulthood. 
 
The most significant of the psychiatric illnesses seen in 22q11DS are the schizophrenia spectrum 
disorders, occurring in 10–25% of affected individuals, beginning in late adolescence/early 
adulthood; also seen are bipolar illness and major depression, which develop in 10–15% of these 
individuals (Shprintzen et al., 1992; Pulver et al., 1994; Papolos et al., 1996; Murphy et al., 
1999). Overall, it is estimated that 25–40% will suffer from a major psychiatric disorder, with up 
to 60% experiencing a major or minor psychiatric disorder (Bassett et al., 2005). Since only 3% 
of individuals with learning disabilities/mental retardation are thought to develop a psychotic 
illness (Fraser et al., 1994), the relationship between schizophrenia and 22q11DS is unique and 
remarkable. Understanding the neural underpinnings of neurocognition and psychosis in 
22q11DS should enable better understanding of the neurodevelopmental processes occurring in 
schizophrenia in the general population, since there is preliminary evidence that the course of 
schizophrenia in individuals with 22q11DS is similar to that seen in the general population 
(Bassett et al., 2003). 
 
Among the neurodevelopmental abnormalities in children with 22q11DS is a markedly high 
frequency of cognitive deficits (80–100%), with most having an IQ between 70–80 (Swillen et 
al., 1997; Gerdes et al., 1999; Moss et al., 1999; Woodin et al., 2001). We have previously 
reported that children with the deletion have deficits in sustained attention, executive function 
and verbal memory, paralleling the deficits seen in individuals with schizophrenia and those at 
high-risk for the disorder (Lewandowski et al., 2007). Quantitative MRI studies in children with 
22q11DS (prior to the onset of psychosis) have shown wide-spread gray matter reductions, 
mainly in the posterior and temporal cortices, the cerebellum and the hippocampus, with relative 
preservation of the frontal lobes (Eliez et al., 2000; Eliez et al., 2001; Simon et al., 2005; 
Debbane et al., 2006). In contrast, in individuals deemed to be at high-risk (offspring of 
individuals with schizophrenia) and ultrahigh-risk (prodromal) for the disorder in the general 
population, the most consistent neuroimaging findings are loss of gray matter in the anterior 
cingulate gyrus, medial temporal lobe and the prefrontal cortices (Keshavan et al., 2004; Wood 
et al., 2008). More studies are needed in these different groups to determine similarities and 
differences in these vulnerable populations. 
 
A small number of cross-sectional studies have provided preliminary data that suggest that the 
relative increases/decreases in gray matter can be associated with lower IQ and behavioral 
abnormalities in children with 22Q11DS (Bearden et al., 2004; Antshel et al., 2005; Kates et al., 
2005; Campbell et al., 2006; Kates et al., 2006; Deboer et al., 2007). A recent study found that a 
reduction in the cingulate gyrus was associated with poor executive function (Dufour et al., 
2008). However, there has been no one study thus far that has examined the relationship between 
the specific neurocognitive measures that are thought to be highly relevant to neurocognition in 
schizophrenia, such as sustained attention, executive function, verbal memory (Kern et al., 2004) 
and the gray matter volumes, in children with 22q11DS. 
 
We set out to perform an integrative study of the neuropsychological and brain structural 
findings in children with 22q11DS, to determine the neural correlates of neurocognition. Our 
hypotheses, based on the literature, were that children with 22q11DS would have reductions of 
gray matter in the parietal, temporal and occipital regions of the cortex and the cerebellum, as 
well as relative preservation of gray matter in the frontal lobes. We also hypothesized that the 
volumetric changes in brain regions that are important for neurocognitive tasks such as the 
temporal, parietal and frontal lobes and the cerebellum would be correlated with sustained 
attention, executive function and verbal working memory, providing evidence that alterations of 
brain structure are accompanied by abnormalities in neurocognition, in childhood. The 
relationship between such findings and psychotic illness would need further longitudinal studies. 
 
MATERIALS AND METHODS 
Subjects 
The participants were 22 children with 22q11DS (mean age 12.8 years, SD=2.14, age range 9 
years to 16 years and 9 months) and 16 age- and gender- matched control subjects (mean age 
12.89 years, SD=2.04, age range from 9 years 9 months to 16 years 3 months). No significant 
age difference was found between the 22q11DS and control subjects. The 22q11DS sample 
included 15 males and seven females and the control group consisted of 10 males and six 
females. The ethnicity of the sample, inclusive of patients and controls, was 90% Caucasian and 
10% African American. 
 
All 22q11DS participants had fluorescence in-situ hybridization confirmation of their diagnosis. 
The subjects were recruited from the Medical Genetics Clinics of Wake Forest University Health 
Sciences (WFUHS), Carolinas Medical Center, the local public school system and private 
pediatric practices in the community. A three-generation pedigree was assessed for the presence 
of mental illness, learning disabilities or other problems that could indicate family members 
affected with 22q11DS, or another developmental or genetic disorder (MNB). Control subjects 
with a personal or family (first-degree relative) history of a psychotic illness, or a personal 
history of mental retardation/developmental delay or multiple congenital anomalies were 
excluded from the study. For children with 22q11DS, the occurrence of psychosis in family 
members affected by 22q11DS was not considered as an exclusion criterion. However, the 
occurrence of psychosis in family members who did not have 22q11DS resulted in exclusion. 
None of the patients or control subjects had a psychotic illness at the time of the study. Control 
subjects were recruited from the local public school system. Those with an IQ over 115 were 
excluded as control subjects, to enable reasonable comparison between the patient and control 
groups. Forty six percent of the patients and 44% of the control participants were diagnosed with 
AD/HD, with 23% and 25% respectively prescribed medication for AD/HD at the time of the 
assessment. The high percentage of control subjects with AD/HD was due to the fact that many 
of the children who participated in the study did so because they had experienced learning 
difficulties, thus providing the parents with an impetus to obtain more information through 
psychoeducational testing offered as part of the study. Since AD/HD is one of the more common 
causes of learning difficulties, it is not surprising that we saw such a high incidence of this in the 
control subjects. This high incidence of AD/HD in the control participants avoids potential 
confounding results and poses an advantage. 
 
Control and patient subjects received a targeted examination to detect dysmorphic features (VS). 
The institutional review boards of all the medical centers where the study was conducted 
approved the study. 
 
 
 
MRI Studies 
Imaging studies were performed at WFUHS, with a General Electric (GE) 1.5 Tesla Signa 
System running 8.4 M4 software. A set of sagittal scout images (2D fast spin echo, TR=2,500 
ms, echo time (TE) =88 ms, FOV=240 mm, approximately 10 slices, slice thickness=5 mm, slice 
gap=1.5 mm, NEX=1, matrix=256×128, scan time=50s) were collected to verify patient position, 
cooperation and image quality. A set of T2 weighted axial images was then collected covering 
the whole brain (2D fast spin echo, TR=3000 ms, TE=36 ms and 96 ms, echo train length (ETL) 
=8, FOV=26×26, approximately 110 slices, slice thickness=3 mm, slice gap=0 mm, NEX=1, 
matrix=256×192). Three-dimensional spoiled gradient echo imaging (SPGR) was performed in 
the coronal plane (SPGR sequence, TR=25ms, TE=5ms, nutation angle=40°, FOV=180 mm in 
the phase encoding direction and 240 mm in the read direction, slice thickness=1.5 mm, NEX=1, 
matrix=256×192, scan time=10 minutes and 18 seconds) to obtain 124 images covering the 
entire brain. 
 
Voxel-based morphometric (VBM) analyses- (DG, KP and MSK) 
A whole brain voxel-wise analysis using an optimized voxel-based morphometry approach was 
run using statistical parametric mapping version 5 (SPM5) that assesses differences in gray 
matter concentration at a microstructural level across the whole brain to identify areas of interest 
(Ashburner et al., 2000). We used a pediatric template (CCHMC2 template, Children’s Hospital 
Medical Center, Cincinnati, OH) to normalize the images because of the age range of study 
subjects. The CCHMC2 template was generated using 148 healthy children, 69 boys and 79 
girls, with an age range of 5–18 years, mean of 11.32, SD of 3.49 years (Wilke et al., 2002). The 
CCHMC2 template avoids the bias caused by the normalization of pediatric images to the MNI 
template that represents mainly the adult brain. Thus, errors in image registration and erroneous 
group differences are averted. 
 
MR images were segmented and extracted in native space (to remove scalp, skull tissue and 
dural venous sinus voxels). Extracted gray matter segments were normalized to the gray matter 
templates, allowing optimal normalization of gray matter and smoothed by convolving with a 12 
FWHM Gaussian kernel. Unmodulated images were analyzed and thresholded to identify 
clusters of significance. Since cluster-level significance is known to produce false positive 
results, only voxel-level results were used (Ashburner et al., 2000; Honea et al., 2005). We 
obtained the reciprocal Talairach Deamon and AAL atlas coordinates to classify the locations of 
significance. 
 
Based on the VBM analytical findings, we extracted gray matter volumes of the regions of 
interest, using the modulated images. We used the WFU PickAtlas program to mask the regions 
of interest. Using the modulated images with volumetric data, number of voxels that subtend 
within the mask and the proportion of gray matter within each voxel were used to calculate the 
volume. Compared to manually defined regions of interest, the masks used in the WFU Atlas 
have been demonstrated to reliably include the regions of interest (Maldjian et al., 2003). These 
quantitative data were then used for statistical analyses to confirm the VBM findings, as well as 
to determine the relationship between the neuropsychological and MRI findings. 
 
 
 
Neuropsychological Assessment (TRK and JK) 
Intelligence testing was performed with the Wechsler Intelligence Scale for Children (WISC) 
using version III for earlier subjects and IV for subjects who were enrolled later. In order to 
minimize inequities between the two versions, we report the Verbal Comprehension Factor 
/Perceptual Organization Factor from the WISC- III and the Verbal Comprehension 
Index/Perceptual Reasoning Index from the WISC-IV. We assessed attention/vigilance, verbal 
learning and reasoning and problem-solving, domains that are frequently impaired in individuals 
with schizophrenia, based upon the NIMH Measurement and Treatment Research to Improve 
Cognition in Schizophrenia (MATRICS) task force recommendations (Kern et al., 2004). 
Executive functioning was measured with the perseverative errors and conceptual level response 
indices from the Wisconsin Card Sort Test (WCST) (Chelune et al., 1986). Sustained attention 
was assessed with the identical pairs (IP) and the AX conditions of the Continuous Performance 
Test (CPT) (Cornblatt et al., 1985; Erlenmeyer-Kimling et al., 2000). In addition, we assessed 
verbal learning and memory with the California Verbal Learning Test (CVLT-C) (Delis et al., 
1994). A semistructured interview was administered to the caregivers to ascertain psychiatric 
diagnoses (C-DISC), based on the DSM-IV criteria for mental disorders (National Institutes of 
Mental Health 2000). 
 
Statistical Analyses 
VBM Analyses. We first conducted estimation of the design using ANCOVA (age and gender as 
covariates). Then, we set up the contrasts between the groups using independent sample t-tests. 
Extent threshold was set to uncorrected p = 0.001 and the minimum cluster size allowed was 25 
voxels. We report on the peak voxel-level p value within these clusters, false discovery rate 
(FDR) corrected for multiple comparisons. Minimum acceptable FDR was set to p<0.05. 
 
Region of Interest Analyses with the Extracted Volumes. In order to examine whether the 
22q11DS and control groups differed on gray matter volumes, ANCOVA was performed with 
age, sex, and total intracranial volume as covariates. The results and effect sizes (eta2) are 
presented for each analysis. This statistic indicates the proportion of the total variance in the 
sample accounted for by each effect (note that eta2 was selected rather than the partial eta2 
statistic given the limitations described by Levine & Hullett (Levine. 2002) . Following Cohen 
an effect size of 0.35 is considered large, 0.15 is considered medium and 0.02 is considered small 
(Cohen. 1988). 
 
We next examined the relationship of gray matter volumes with intellectual ability, sustained 
attention, executive functioning and verbal learning and memory using hierarchical regression 
analyses. In each analysis, a measure of neurocognitive performance was included as the 
criterion. Sex, age, and total intracranial volume were entered at the first step, regional brain 
volume at the second step, group at the third step and the group x brain volume interaction at the 
final step. The interaction term allowed us to examine whether the relationship between brain 
volume and neurocognitive performance was different for the 22q11DS and control groups. 
 
RESULTS 
Qualitative MRI Analysis 
An MRI abnormality was seen in 17/22 of the 22q11DS subjects on routine MRI analysis; three 
had subcortical white matter densities, one had an Arnold-Chiari type 1 malformation; 14 had a 
cavum septum pellucidum (CSP) of more than 4 mm in size (one subject had both a CSP and the 
Arnold-Chiari malformation). Four of the 16 controls had an MRI finding of a CSP of over 4 
mm. There were no significant differences between the 22q11DS and control groups in the 
occurrence of any MRI finding or a CSP (p=0.09 and 0.2 respectively, Fisher’s exact test). 
However, all of the CSPs that were large in size (25–50 mm) occurred only in the 22q11DS 
group (n=7/22) [p=0.03]. 
 
VBM Analysis 
Subjects with 22q11DS had significantly reduced gray matter in several regions of the brain, 
when compared to the control subjects (Table 1, Figure 1–Figure 2). Specifically, the anterior 
and middle cingulate gyri, the lingual gyrus, the cuneus and culmen of the cerebellum, the 
fusiform gyrus, the middle and inferior frontal gyri, the amygdala and the caudate nucleus were 
volumetrically reduced in the 22q11Ds group, relative to controls. 
 
Table 1: VBM analyses (voxel-level) of Gray Matter Reductions in children with 22q11DS (n=22) 
compared to Control Subjects (n=16). Height threshold: T=3.37, extent threshold: k=25 voxels. 
Brain Regions Cluster Size (1 mm3 voxels) Talaraich/AAL Atlas coordinates mm Voxel-level PFDR-corrected 
Lingual gyrus left 3282 −2 −68 0 0.001 
Cuneus right 324 14 −86 40 0.001 
Anterior cingulate right 367 12 40 26 0.001 
Superior temporal right 204 54 2 4 0.002 
Middle cingulate right 109 12 20 46 0.002 
Inferior frontal right 82 60 6 22 0.002 
Subgyral right 120 50 −18 20 0.002 
Amygdala left 86 −24 −8 −14 0.003 
Middle frontal right 42 48 4 54 0.003 
Inferior frontal left 58 −46 42 18 0.005 
Culmen left 287 −20 −44 −16 0.007 
Inferior parietal lobule 97 −52 −58 42 0.008 
Fusiform left 56 −52 2 32 0.010 
Caudate right 49 10 22 2 0.010 
 
Figure 1: Reduced gray matter in the cingulate gyrus in children 
with 22q11Ds compared to controls. Also evident are the decrease 
in gray matter in the occipital regions in the 22q11DS group. 
 
 
 
 
 
 
Figure 2: Reduction in gray matter in the cerebellar regions in 
children with 22q11DS 
 
 
 
 
 
 
 
 
Extracted Volumes Analyses 
The total intracranial volume (ICV) in the 22q11DS group was not reduced as compared to the 
control group (mean ICV in 22q11DS= 1324.1 cc, SD= 169.6 and mean ICV in control group= 
1357cc, SD= 176.8, p=0.2). Thus, it was deemed appropriate to partial out variance associated 
with ICV as well as age and gender, from the correlations of groups and brain volumes (note that 
in cases of nonrandom assignment, variables that differ between groups cannot be used as 
covariates, contrary to common wisdom (Miller et al., 2001). We performed ANCOVA on the 
patient and control groups and were able to confirm the reduced gray matter within the anterior 
and middle cingulate gyri, areas corresponding to the dorsolateral prefrontal cortex (DLPFC), the 
cerebellum, lingual gyrus and the left fusiform gyrus. Additionally, the posterior cingulate and 
the substantia nigra on both sides and the left subthalamus were also volumetrically reduced in 
the 22q11DS group (Table 2). 
 
Table 2: Comparison of 22q11DS and control group on gray matter volumes (mm3) with age, 
sex and intracranial volume as covariates 
Brain Region 22q11DS group  Control Group F-value Effect Size (η2) 
Mean (SD)  Mean (SD)   
Anterior cingulate L 5575.4 (614.5)  5840.7 (581.1) 1.56 0.035 
Anterior cingulate R 5209.9 (623.6)  5701.0 (634.6) 6.79* 0.100 
Middle cingulate L 7501.0 (773.3)  8108.6 (827.3) 6.40* 0.135 
Middle cingulate R 8769.3 (865.8)  9670.3 (978.2) 10.43** 0.193 
Posterior cingulate L 1237.0 (148.5)  1463.9 (233.3) 13.61*** 0.282 
Posterior cingulate R 599.8 (94.8)  772.9 (153.9) 17.16*** 0.338 
Amygdala L 778.2 (85.6)  786.3 (117.1) 0.15 0.003 
Amygdala R 1013.0 (85.4)  1004.3 (98.2) 0.06 0.001 
Caudate nucleus L 3142.7 (439.5)  3393.6 (543.8) 3.06 0.075 
Caudate nucleus R 3346.2 (470.3)  3414.1 (524.4) 0.45 0.011 
Fusiform L 8942.6 (1119.8)  9524.4 (958.5) 6.05* 0.098 
Fusiform R 9052.8 (1187.5)  9533.9 (1068.0) 2.51 0.024 
Pallidum L 653.5 (136.5)  727.9 (131.7) 3.49 0.090 
Pallidum R 784.4 (153.7)  841.4 (157.7) 2.30 0.058 
Subthalamus L 16.3 (5.5)  11.6 (4.8) 5.91* 0.146 
Subthalamus R 11.1 (4.9)  10.5 (3.4) 0.13 0.004 
Substantia nigra L 23.4 (11.8)  35.2 (9.5) 15.05*** 0.292 
Substantia nigra R 20.9 (11.3)  33.5 (10.3) 16.76*** 0.303 
Brodmanns’ area L 9 4465.7 (644.7)  4901.1 (828) 4.34* 0.109 
Brodmann’s area R 9 4928.0 (580.5)  4639.7 (734.8) 3.84 0.093 
Cerebellum L 48591.7 (5716.7)  52967.2 (6628.5) 8.58** 0.141 
Cerebellum R 48813.6 (5981.3)  54645.4 (6172.5) 12.25** 0.143 
Medium and large effect sizes (η2) are bolded. *p<0.05. **p<0.01. ***p<0.001. 
Note: corrections for multiple testing were not applied here because these areas were significant at FDR-corrected p<0.05. 
 
Summary of cognitive data in the 22q11DS group, compared to the control group 
The details of the neurocognitive deficits in the 22q11DS group are published elsewhere 
(Lewandowski et al., 2007), but we wish to emphasize that there were significant differences in 
IQ between the 22q11DS and control groups. The mean IQ of the 22q11DS children was 73.3 
(SD= 11.5) as compared to the control subjects (mean= 106, SD=13.6. t=-8.05). Similarly, there 
were significant differences between the two groups in sustained attention, executive function 
and verbal memory, with the 22q11DS group demonstrating worse performance, even after 
partialling out variance associated with verbal and performance IQ (Lewandowski et al., 2007). 
 
We examined the relationship between gray matter volumes that were significantly different in 
the 22q11DS group and neurocognitive performance using hierarchical regression analyses (a 
representation of these are presented in Table 3, Table 4, and Table 5), the 22q11DS patients 
performed worse than the control group on the neurocognitive measures (note that positive betas 
indicate superior performance by the control group). We found significant correlations between 
the volumetric gray matter reductions in the DLPFC, the cingulate gyrus, the cerebellum and 
tests of higher neurocognition in both the patient and control groups. Other regional gray matter 
reductions were not associated with the neurocognitive measures in either the 22q11DS or 
control groups. (Lewandowski et al., 2007). 
 
Table 3: Relationship of right Brodmann’s area 9 and neurocognitive performance, a 
representation of the correlations between brain gray matter volumes and neurocognition in this 
study 
Criterion Step 1  Step 2  Step 3  Step 4 
Age, Sex, ICV  Right Brodmann’s area 9 
 
 Group  Interaction 
β Δr2 f2  β Δr2 f2  β Δr2 f2  β Δr2 f2 
WISC Verbal comp -- 0.243* 0.32  
 
0.40 0.149* 0.25  
 
0.59 0.282*** 0.87  
 
0.05 0.002 0.01 
WCST_PE -- 0.106 0.12  
 
0.21 0.039 0.05  
 
0.41 0.145* 0.20  
 
−0.14 0.016 0.02 
WCST_CLR -- 0.196 0.24  
 
0.29 0.076 0.10  
 
0.51 0.220*** 0.43  
 
−0.02 0.000 0.00 
CPT_AX -- 0.234* 0.31  
 
0.15 0.020 0.03  
 
0.72 0.438*** 1.40  
 
−0.04 0.001 000 
CPT_IP -- 0.220* 0.28  
 
0.22 0.044 0.06  
 
0.60 0.303*** 0.70  
 
−0.01 0.000 0.00 
CVLT 1–5 -- 0.189 0.23  
 
0.26 0.061 0.08  
 
0.48 0.193** 0.34  
 
0.16 0.021 0.04 
Medium and large effect sizes (f2) are bolded. Positive β at step 2 indicate larger volume is associated with better cognitive performance, at step 3 
indicates better cognitive performance in the control group than in the 22q11DS patient group. 
*p < 0.05. **p<0.01. ***p<0.001. 
 
 
Table 4: Relationship of right posterior cingulate volume and neurocognitive performance 
Criterion Step 1  Step 2  Step 3  Step 4 
Age, Sex, ICV  Right posterior cingulate 
 
 Group  Interaction 
β Δr2 f2  β Δr2 f2  β Δr2 f2  β Δr2 f2 
WISC Verbal comp -- 0.243* 0.32  
 
0.55 0.298*** 0.65  
 
0.50 0.129** 0.40  
 
0.01 0.000 0.00 
WCST_PE -- 0.106 0.12  
 
0.26 0.067 0.08  
 
0.44 0.115* 0.16  
 
0.10 0.005 0.01 
WCST_CLR -- 0.196 0.24  
 
0.36 0.127* 0.19  
 
0.52 0.161** 0.31  
 
0.04 0.001 0.00 
CPT_AX -- 0.234 0.31  
 
0.37 0.132* 0.21  
 
0.71 0.320*** 1.02  
 
−0.10 0.006 0.02 
CPT_IP -- 0.220 0.28  
 
0.45 0.200** 0.34  
 
0.51 0.163** 0.39  
 
0.19 0.021 0.05 
CVLT 1–5 -- 0.189 0.23  
 
0.31 0.093* 0.13  
 
0.49 0.153** 0.27 0.36 0.078* 0.16 
Medium and large effect sizes (f2) are bolded. Positive β at step 2 indicate larger volume is associated with better cognitive performance, at step 3 
indicates better cognitive performance in the control group than in the 22q11DS patient group. 
*p < 0.05. **p<0.01. ***p<0.001. 
 
 
There was no significant difference in the diagnosis of AD/HD or stimulant medication status 
between the 22q11DS and control groups that could have caused confounding results on the 
neurocognitive tests. 
 
 
Table 5: Relationship of right cerebellum volume and neurocognitive performance 
Criterion Step 1  Step 2  Step 3  Step 4 
Age, Sex, ICV  Right cerebellum  Group  Interaction 
β Δr2 f2  β Δr2 f2  β Δr2 f2  β Δr2 f2 
WISC Verbal comp -- 0.243 0.32  
 
0.56 0.168** 0.29  
 
0.61 0.232*** 0.65  
 
0.01 .000 0.00 
WCST_PE -- 0.106 0.12  
 
0.29 0.042 0.05  
 
0.46 0.141* 0.20  
 
0.15 .021 0.03 
WCST_CLR -- 0.196 0.24  
 
0.45 104* 0.15  
 
0.53 0.183** 0.35  
 
0.14 .016 0.03 
CPT_AX -- 0.234 0.31  
 
0.47 0.113* 0.17  
 
0.70 0.338*** 1.08  
 
−0.05 .002 0.00 
CPT_IP -- 0.220 0.28  
 
0.45 0.108* 0.16  
 
0.59 0.239*** 0.55  
 
0.22 .041 0.10 
CVLT 1–5 -- 0.189 0.23  
 
0.37 0.072 0.10  
 
0.50 0.173** 0.31  
 
0.11 0.010 0.02 
Medium and large effect sizes (f2) are bolded. Positive β at step 2 indicate larger volume is associated with better cognitive performance, at step 3 
indicates better cognitive performance in the control group than in the 22q11DS patient group. 
*p <0.05. **p<0.01. ***p<0.001. 
 
 
DISCUSSION 
Our study examined gray matter volumetric changes in children with 22q11DS and the relation 
between such changes and neurocognitive performance. Delineating premorbid findings in a high 
risk group, such as children with 22q11DS, should increase the understanding of the 
pathogenesis of schizophrenia and other psychoses. This study is focused on the gray matter 
changes occurring in childhood in 22q11DS and thus the discussion is centered around these 
findings. Functional MRI studies and structural MRI studies that delineate white matter changes 
as well as structural changes in adults with 22q11DS are beyond the scope of this article. 
 
Qualitative analysis of the brain images indicated that a CSP was frequent in the 22q11DS group. 
A CSP is thought to be indicative of maldevelopment of structures bordering it, such as the 
amygdala and the cingulate gyrus and has been reported both in children with 22q11DS (Mitnick 
et al., 1994; Bingham et al., 1997; Vataja et al., 1998; Shashi et al., 2004) and adults with 
22q11DS who have schizophrenia (Chow et al., 1999; van Amelsvoort et al., 2001). It is said to 
occur in up to 45% of individuals with schizophrenia in the general population (Shenton et al., 
2001), although others report no association between a CSP and schizophrenia or high-risk status 
(Rajarethinam et al., 2008). We found no significant difference in the frequency of a CSP 
between the 22q11DS subjects and the control groups; however, remarkably large CSPs (25–50 
mm in size, some filling the entire lateral ventricles) occurred exclusively in the 22q11DS 
subjects (p=0.03). We suggest that a large CSP in children with 22q11DS is likely to be a marker 
of abnormal neurodevelopment of adjacent structures such as the cingulate gyrus. 
 
A reduction in total intracranial volume (ICV) has been reported in schizophrenia (Vita et al., 
2006). Although reduction in ICV have been reported in individuals with 22q11DS (with and 
without psychosis), careful perusal of such reports indicated that many were not significant 
(Eliez et al., 2000; Chow et al., 2002; Kates et al., 2004). We did not find a significant difference 
in ICV between the 22q11DS and controls subjects in our study. However, confounding factors 
such as a small sample size and a population of controls that are not “typical” could have 
resulted in this finding in our study. 
 
 
Gray matter changes in 22q11DS 
Previous reports of morphometric MRI analyses of gray matter in 22q11DS children prior to the 
development of psychoses, have found reductions in the parietal and occipital lobes, cerebellum, 
cingulate gyrus, superior temporal gyrus and hippocampus (Usiskin et al., 1999; Eliez et al., 
2000; Eliez et al., 2001; Eliez et al., 2001; Kates et al., 2001; Simon et al., 2005; Bearden et al., 
2006; Bish et al., 2006; Campbell et al., 2006; Bearden et al., 2009). Relatively preserved gray 
matter within the frontal lobes and the insula and an increase in the volume of the caudate body 
have been reported (Sugama et al., 2000; Eliez et al., 2002; Kates et al., 2004; Simon et al., 
2005). However, other studies found a trend towards decreased frontal and prefrontal areas, in 
males with 22q11DS (Kates et al., 2005) and decreased gyrification in the frontal lobes [this 
study included both children and adults with 22q11DS] (Schaer et al., 2006). We discuss below 
the VBM and extracted volume analyses in children with 22q11DS, relative to control subjects. 
 
We found significant decreases in the DLPFC gray matter (middle frontal gyrus, Brodmann’s 
area 9) in children with 22q11DS, contrary to our expectation of preserved frontal lobe gray 
matter. However, the reduction in the DLPFC was not as robust as gray matter reductions in the 
cerebellum and cingulate. Although it is thought that in the general population, DLPFC 
reductions occur later in the trajectory of events on the pathway to psychosis, consistent with the 
“back to the front” theory of synaptic pruning in adolescence (Rapoport et al., 2005), we have 
insufficient evidence to suggest this in our patient population, due to the cross-sectional nature of 
our study. Gray matter losses in the DLPFC, the seat of neurocognitive function in the domains 
of sustained attention, executive function and working memory (Goldman-Rakic et al., 1991), 
are reported in schizophrenia (Tandon et al., 2008). Similarly, reductions in DLPFC gray matter 
have been described in individuals at high-risk of schizophrenia in the general population 
(Pantelis et al., 2003; Wood et al., 2008). 
 
All subregions of the cingulate gyrus showed gray matter reductions in our cohort of 22q11DS 
children, consistent with two previous reports (Simon et al., 2005; Campbell et al., 2006). Note 
that reductions in gray matter within the anterior cingulate have been consistently reported in 
schizophrenia (Glahn et al., 2008); less frequent are reductions in the middle and posterior 
cingulate (Wolf et al., 2008). In prodromal individuals, a loss of anterior cingulate gray matter 
occurred in those that went to develop psychosis, suggesting that such reductions may be 
predictive of psychosis in ultra high-risk individuals (Pantelis et al., 2003; Wood et al., 2008). 
 
Volumetric gray matter reductions in the cerebellum and lingual gyrus in the 22q11DS group in 
this study are consistent with previous reports (Eliez et al., 2001), indicating that these reductions 
are an integral part of the neurodevelopmental abnormalities in 22q11DS. Similar cerebellar gray 
matter reductions have been described in schizophrenia, but the exact significance remains 
poorly understood (Shenton et al., 2001). Since the cerebellum is believed to be important in 
mediating the cognitive deficits seen in schizophrenia (Andreasen et al., 1999), the cerebellar 
reduction may prove to be important in neurocognition in individuals with 22q11DS. 
 
Previously gray matter reductions of the hippocampus, and increases within the basal ganglia or 
insula have been reported (Eliez et al., 2002; Simon et al., 2005; Campbell et al., 2006; Debbane 
et al., 2006; Deboer et al., 2007), while findings regarding the amygdala gray matter volumes 
have been equivocal (Debbane et al., 2006; Kates et al., 2006; Deboer et al., 2007). A reduction 
in gray matter in regions of the basal ganglia including the caudate, and the amygdala was 
detected in our 22q11DS subjects. Such inconsistencies from one study to another may partly be 
explained by methodological differences (e.g., using total gray matter vs. intracranial volume as 
a covariate, varying templates for analyses and differences in subjects’ ages). Thus, uniformity of 
methods should minimize confounding findings. 
 
Correlations between gray matter changes and neurocognition in 22q11DS 
Our study is the first to report that gray matter reductions in the DLPFC, cingulate and 
cerebellum are correlated with poor performance in executive function, sustained attention and 
verbal memory, in children with 22q11DS. A few previous studies have examined the 
relationship between gray matter volumes in 22q11DS and the cognitive deficits seen in 
childhood. One study reported no correlations of DLPFC reduction with executive function, 
working memory or facial recognition, in boys with 22q11DS (Kates et al., 2005); however, the 
control group demonstrated an association between DLPFC reduction and planning and 
organization (Kates et al., 2005). A second study reported that reduction in hippocampal volume 
was associated with lower verbal IQ (Deboer et al., 2007). Thinning of the frontal cortex is 
reported to correlate with cognitive abilities (Bearden et al., 2009). Other studies that have 
examined the functional correlates of gray matter changes in 22q11DS have concentrated on 
behavior and minor psychiatric diagnoses, rather than neurocognition (Eliez et al., 2001; Bearden 
et al., 2004; Campbell et al., 2006; Kates et al., 2006), emphasizing the need for further studies 
of neurocognition and brain volumes. 
 
Our finding of correlations between the DLPFC gray matter reductions in the 22q11DS group 
and poor neurocognitive performance, previously unreported, parallels similar reports in 
individuals with schizophrenia (Antonova et al., 2004) as well as high-risk individuals 
(Keshavan et al., 2004). We believe that the DLPFC is associated with neurocognition in healthy 
control subjects as well, since we found a positive correlation between DLPFC volumes and 
neurocognition in this group. 
 
The anterior cingulate is integral to affect and cognition via its projections to the prefrontal 
regions (Yucel et al., 2003) and disturbances in cingulate functioning are associated with 
executive dysfunction in schizophrenia (Rusch et al., 2007), as well as the affective and 
attentional symptoms seen in high-risk individuals (Wood et al., 2008). Our finding of 
volumetric reduction in the subregions of the cingulate is similar to previous reports in children 
with 22q11DS (Simon et al., 2005; Campbell et al., 2006), including as association between the 
anterior cingulate reductions and cognition (Simon et al., 2005) and cingulate volume and 
executive function (Dufour et al., 2008), but this is the first study to report correlations between 
such reductions and performance associated with the cognitive phenotype in schizophrenia, 
namely executive functioning, sustained attention and verbal working memory. 
 
The cerebellum has been long known to play a critical role in coordination and fine motor 
control, but recently it has been reported to influence cognitive processes such as planning and 
problem solving (Schmahmann et al., 1998). Impairment of these functions are thought to 
underlie the “cognitive dysmetria” seen in schizophrenia (Andreasen et al., 1999). We found 
reduced cerebellar gray matter was associated with impairments in sustained attention, executive 
functioning, verbal working memory and IQ in both the 22q11DS and control participants, 
emphasizing the role of the cerebellum in neurocognition. However, the relationship of the 
cerebellar gray matter reduction to the development of psychosis associated with 22q11DS is as 
yet unclear (Eliez et al., 2001; van Amelsvoort et al., 2001; van Amelsvoort et al., 2004). Only 
one study examined the differences in volume reduction of the cerebellum, in 22q11DS adults 
with and without schizophrenia and found no differences between the two groups (van 
Amelsvoort et al., 2004). Longitudinal studies (ongoing in our study) will help determine the 
relationship between the cerebellar gray matter reductions and schizophrenia. 
 
The finding that the gray matter volume x group interactions generally did not account for 
increments in variance, suggests that 22q11DS does not moderate the relations between gray 
matter and neurocognition (i.e., gray matter changes impact neurocognition comparably in the 
patients and the control subjects). Thus, the marked neurocognitive impairment in 22q11DS 
appears to be associated with disruptions in neurodevelopment that result in significant gray 
matter reductions in the patients 
 
We found no associations between gray matter volumes and neurocognition in areas such as the 
fusiform gyrus and amygdala; areas that are important in other functions such as face recognition 
(fusiform gyrus) or anxiety (amygdala). Similarly, the lack of correlation between the reduction 
of the superior temporal gyrus, inferior parietal lobule and cognitive performance may reflect 
that these areas are critical to other functions, such as language or visual-spatial function. 
 
A small sample size is a limitation to the study, but nonetheless we were able to demonstrate 
significant effects. In addition, VBM, although widely used, is not ideal to quantify small 
structures such as the substantia nigra and thus abnormalities of these structures may not be 
accurately detected (Kennedy et al., 2008). However, we eliminated common confounders of 
VBM, such as motion artifact; and the age of our study subjects was within 1 SD of the age of 
the children used to generate the pediatric template data. Thus, we have minimized the cross-
registration errors that could be seen as differences in voxel intensities. 
 
One of the strengths of our study is that our 22q11DS subjects are more likely representative of 
the spectrum of developmental problems that occur in this condition, since they were not 
ascertained through a pediatric specialty clinic (e.g., psychiatry, cardiology, ENT), but through 
general genetics clinics, wherein children are evaluated with no bias towards psychological 
manifestations. We also chose psychological measures that are known to reliably assess the 
deficits that are central to the neurocognitive phenotype of schizophrenia (Kern et al., 2004). 
Furthermore, the neuroimaging data is based upon a pediatric template, thereby avoiding the 
possible confounding effects of an adult template. Finally, we used a convergent approach to 
morphometric analysis: VBM and the analysis of extracted volumes. 
 
In conclusion, we have demonstrated that reductions in gray matter within the cerebellum, the 
posterior cortices, the cingulate and the DLPFC occur in children with 22q11DS. No areas of 
gray matter excesses were detected in the 22q11DS group. In both 22q11DS and control 
subjects, gray matter volumes within the DLPFC, the cingulate and the cerebellum were 
positively correlated with performance in the domains of sustained attention, executive function 
and verbal memory, in addition to intelligence, strengthening the concept that these brain regions 
are important mediators of neurocognition. Longitudinal study of this and similar samples should 
enhance our understanding of the trajectory of brain development and neurocognition during 
adolescence, and the relevance of such findings to the development of schizophrenia in later life. 
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